(Note: For PDF File Swipe To The End Of Article)
Pre-eclampsia
Introduction / Definition
Pre-eclampsia is a serious multisystem disorder that occurs during pregnancy, usually after 20 weeks of gestation, and is characterized mainly by high blood pressure and signs of damage to other organs, particularly the kidneys, liver, brain, and placenta. It is one of the most important causes of maternal and fetal morbidity and mortality worldwide. The condition can range from mild hypertension with minimal symptoms to severe disease involving seizures, stroke, liver failure, kidney injury, placental abruption, and fetal death.
Pre-eclampsia develops only during pregnancy or shortly after delivery. In most cases, it appears during the third trimester, but it may also occur earlier in pregnancy, especially in women with high-risk factors. The disorder resolves after delivery of the placenta, which strongly suggests that placental abnormalities play a central role in its development.
Traditionally, pre-eclampsia was diagnosed when a pregnant woman developed hypertension along with proteinuria after 20 weeks of gestation. However, modern diagnostic criteria recognize that the disease may also occur without proteinuria if there is evidence of organ dysfunction such as thrombocytopenia, impaired liver function, pulmonary edema, cerebral symptoms, or renal insufficiency.
The condition is extremely important in obstetrics because it can rapidly progress to life-threatening complications. Early recognition, regular antenatal monitoring, and proper management are essential to reduce complications for both mother and fetus.
Epidemiology
Pre-eclampsia affects approximately 2–8% of pregnancies worldwide. The incidence varies between countries depending on healthcare access, maternal nutrition, prenatal care, socioeconomic status, and prevalence of risk factors such as obesity and chronic hypertension.
The disorder is more common in developing countries where antenatal care services may be limited. Maternal mortality due to hypertensive disorders of pregnancy remains a major public health concern in many low-income regions. In developed countries, improved prenatal surveillance and modern obstetric care have significantly reduced mortality rates, although complications still occur.
Pre-eclampsia contributes greatly to premature birth and neonatal intensive care admissions. Many babies born to mothers with severe disease are delivered early due to maternal or fetal complications. This increases the risk of respiratory distress syndrome, low birth weight, feeding difficulties, and developmental problems in newborns.
The disease can affect women of all ages, but the frequency is higher among teenage mothers and women older than 35 years. It is also more common during first pregnancies compared to subsequent pregnancies with the same partner.
The recurrence risk in future pregnancies depends on the severity and timing of the disease in previous pregnancies. Women who experienced severe early-onset pre-eclampsia have a much greater risk of recurrence compared to those who developed mild disease near term.
Etiology / Causes
The exact cause of pre-eclampsia is not fully understood, but it is believed to result from abnormal placental development combined with maternal vascular and inflammatory responses. Multiple genetic, immunological, environmental, and vascular factors contribute to the disease process.
One of the major theories involves abnormal trophoblastic invasion of maternal spiral arteries during early pregnancy. Normally, these arteries become wide and low-resistance vessels capable of supplying sufficient blood to the placenta. In pre-eclampsia, this remodeling process is defective, leading to poor placental perfusion and placental ischemia.
The ischemic placenta releases inflammatory mediators, antiangiogenic factors, and endothelial toxins into the maternal circulation. These substances damage maternal blood vessels and lead to widespread endothelial dysfunction. As a result, vasoconstriction, increased vascular permeability, platelet activation, and organ ischemia occur.
Genetic predisposition also plays a role. Women with a family history of pre-eclampsia are more likely to develop the disorder. Certain paternal genes may also contribute because the condition is linked to placental genetics.
Immunological factors are important as well. Inadequate maternal immune adaptation to fetal antigens may contribute to abnormal placental implantation and vascular injury.
Environmental and maternal factors such as obesity, malnutrition, diabetes mellitus, chronic hypertension, renal disease, and autoimmune disorders increase susceptibility to the disease.
Risk Factors
Several maternal, fetal, and pregnancy-related factors increase the likelihood of developing pre-eclampsia.
Maternal Risk Factors
- First pregnancy
- Maternal age below 18 years or above 35 years
- Obesity
- Chronic hypertension
- Diabetes mellitus
- Chronic kidney disease
- Autoimmune disorders such as lupus
- Antiphospholipid antibody syndrome
- Family history of pre-eclampsia
- Previous history of pre-eclampsia
- Multiple pregnancies
Pregnancy-Related Risk Factors
Twin or multiple gestation pregnancies increase placental mass and therefore increase the risk of placental dysfunction. Pregnancies conceived through assisted reproductive techniques also carry higher risk.
Lifestyle and Environmental Factors
Poor nutrition, sedentary lifestyle, low socioeconomic status, smoking cessation during pregnancy, and limited prenatal care may contribute indirectly to disease development.
Women with preexisting cardiovascular disease are particularly vulnerable because endothelial dysfunction already exists before pregnancy.
Pathophysiology
The pathophysiology of pre-eclampsia involves abnormal placental implantation followed by widespread maternal endothelial dysfunction.
During normal pregnancy, trophoblastic cells invade maternal spiral arteries and convert them into low-resistance channels capable of supplying adequate blood to the placenta. In pre-eclampsia, this invasion is shallow and incomplete. The spiral arteries remain narrow and resistant, leading to placental hypoperfusion.
Reduced blood flow to the placenta causes ischemia and oxidative stress. The stressed placenta releases harmful substances into maternal circulation, including antiangiogenic factors such as soluble fms-like tyrosine kinase-1 (sFlt-1) and endoglin. These substances interfere with normal endothelial function.
Endothelial injury results in:
- Vasoconstriction
- Increased blood pressure
- Capillary leakage
- Activation of the coagulation system
- Reduced organ perfusion
Kidneys become affected due to glomerular endotheliosis, causing proteinuria and reduced renal filtration. Liver involvement leads to elevated liver enzymes and hepatic pain. Brain involvement produces headaches, visual disturbances, hyperreflexia, and seizures in severe cases.
Placental insufficiency compromises fetal oxygen and nutrient supply, resulting in fetal growth restriction, oligohydramnios, and fetal distress.
The disease therefore represents both placental dysfunction and systemic maternal vascular injury occurring simultaneously.
Classification
Pre-eclampsia can be classified into several categories based on severity and timing.
Mild Pre-eclampsia
Mild disease involves elevated blood pressure with minimal proteinuria and absence of severe organ dysfunction. Patients may have few symptoms and often remain stable with careful monitoring.
Severe Pre-eclampsia
Severe disease includes:
- Very high blood pressure
- Severe proteinuria
- Persistent headache
- Visual disturbances
- Epigastric pain
- Elevated liver enzymes
- Low platelet count
- Pulmonary edema
- Renal impairment
This form requires urgent management because complications may develop rapidly.
Early-Onset Pre-eclampsia
Occurs before 34 weeks of gestation. It is usually associated with severe placental dysfunction and higher maternal and fetal complications.
Late-Onset Pre-eclampsia
Occurs after 34 weeks and is generally associated with better fetal outcomes compared to early-onset disease.
Superimposed Pre-eclampsia
Develops in women who already have chronic hypertension before pregnancy. These women develop new-onset proteinuria or worsening hypertension with organ dysfunction during pregnancy.
Clinical Manifestations
The symptoms and signs of pre-eclampsia vary greatly depending on disease severity. Some women remain asymptomatic while others develop rapidly progressive complications.
The most common clinical feature is hypertension developing after 20 weeks of gestation. Blood pressure readings are typically equal to or greater than 140/90 mmHg on two separate occasions.
Proteinuria is another classical finding and occurs due to renal endothelial damage. Swelling of the face, hands, and feet may occur because of fluid retention, although edema alone is not diagnostic.
Headache is a significant symptom and usually indicates cerebral involvement. The headache is often persistent, severe, and resistant to ordinary analgesics.
Visual disturbances occur due to cerebral edema or retinal vasospasm and may include:
- Blurred vision
- Flashing lights
- Scotomas
- Double vision
- Temporary blindness
Epigastric or right upper quadrant pain results from liver involvement and stretching of the hepatic capsule. This symptom is considered a warning sign for severe disease.
Other manifestations include:
- Nausea and vomiting
- Reduced urine output
- Sudden weight gain
- Hyperreflexia
- Breathlessness due to pulmonary edema
- Anxiety and restlessness
Fetal manifestations may include reduced fetal movements, intrauterine growth restriction, and signs of fetal distress caused by placental insufficiency.
Diagnosis
The diagnosis of Pre-eclampsia is based on clinical assessment, blood pressure measurement, laboratory investigations, and fetal evaluation. Early diagnosis is extremely important because prompt treatment can prevent severe maternal and fetal complications.
According to current diagnostic criteria, pre-eclampsia is diagnosed when a pregnant woman develops hypertension after 20 weeks of gestation along with proteinuria or evidence of maternal organ dysfunction.
Hypertension is defined as:
- Systolic blood pressure ≥140 mmHg
- Diastolic blood pressure ≥90 mmHg
The readings should be recorded on at least two separate occasions several hours apart.
Proteinuria is identified by:
- ≥300 mg protein in a 24-hour urine sample
- Protein/creatinine ratio ≥0.3
- Urine dipstick reading of +1 or greater
However, pre-eclampsia can also be diagnosed in the absence of proteinuria if hypertension is accompanied by:
- Thrombocytopenia
- Elevated liver enzymes
- Renal insufficiency
- Pulmonary edema
- Cerebral symptoms
- Visual disturbances
Careful history taking is important because symptoms such as persistent headache, visual disturbances, abdominal pain, or reduced fetal movements may indicate severe disease.
Physical examination includes:
- Blood pressure monitoring
- Assessment for edema
- Neurological examination
- Reflex assessment
- Respiratory evaluation
- Abdominal examination
Fundoscopic examination may reveal retinal vasospasm or edema in severe cases.
Laboratory Investigations
Laboratory tests are essential for evaluating disease severity and monitoring organ involvement.
Urine Examination
Urinalysis helps detect proteinuria. A 24-hour urine protein measurement provides the most accurate assessment. Dipstick testing is commonly used for screening but is less reliable.
Complete Blood Count
Platelet count is particularly important because thrombocytopenia may indicate severe disease or progression toward HELLP syndrome.
Hemoconcentration may occur due to plasma leakage and reduced intravascular volume.
Liver Function Tests
Elevated liver enzymes such as AST and ALT indicate hepatic involvement. Severe elevation may suggest liver injury or HELLP syndrome.
Renal Function Tests
Serum creatinine and blood urea nitrogen are measured to evaluate kidney function. Reduced renal perfusion may lead to elevated creatinine levels.
Coagulation Profile
Disseminated intravascular coagulation may occur in severe cases, making coagulation studies important.
Serum Uric Acid
Serum uric acid is often elevated in pre-eclampsia due to impaired renal excretion and oxidative stress.
Lactate Dehydrogenase (LDH)
Increased LDH levels may indicate hemolysis or tissue injury.
Fetal Assessment
Because pre-eclampsia affects placental blood flow, careful fetal monitoring is necessary throughout pregnancy.
Ultrasound Examination
Ultrasound evaluates:
- Fetal growth
- Amniotic fluid volume
- Placental condition
- Fetal anatomy
Fetal growth restriction is common in severe placental insufficiency.
Doppler Studies
Umbilical artery Doppler studies assess placental circulation. Abnormal blood flow patterns indicate compromised placental perfusion.
Non-Stress Test
This test monitors fetal heart rate patterns and fetal well-being.
Biophysical Profile
The biophysical profile combines ultrasound findings with fetal heart monitoring to assess fetal health.
Reduced fetal movement or abnormal fetal heart rate patterns may indicate fetal distress and require urgent intervention.
Severe Features of Pre-eclampsia
Certain findings indicate severe disease and require urgent hospitalization and management.
Severe features include:
- Blood pressure ≥160/110 mmHg
- Severe persistent headache
- Visual disturbances
- Pulmonary edema
- Severe epigastric pain
- Elevated liver enzymes
- Platelet count below 100,000/mm³
- Progressive renal insufficiency
- Oliguria
- Cyanosis
- Eclampsia
- Fetal growth restriction
The presence of severe features significantly increases the risk of maternal and fetal mortality.
Complications
Pre-eclampsia can lead to numerous life-threatening complications affecting nearly every organ system.
Maternal Complications
Eclampsia
Eclampsia refers to the occurrence of seizures in a woman with pre-eclampsia. Seizures may occur before, during, or after labor and are caused by severe cerebral involvement.
Eclampsia is a medical emergency associated with:
- Cerebral hemorrhage
- Aspiration pneumonia
- Hypoxia
- Maternal death
HELLP Syndrome
HELLP syndrome is a severe variant characterized by:
- Hemolysis
- Elevated liver enzymes
- Low platelet count
Patients often present with severe epigastric pain, nausea, vomiting, and malaise.
Placental Abruption
Premature separation of the placenta may occur due to vascular injury. This can cause severe bleeding, fetal distress, and maternal shock.
Acute Kidney Injury
Reduced renal perfusion and endothelial damage may lead to renal failure.
Pulmonary Edema
Capillary leakage and cardiac dysfunction can cause fluid accumulation in the lungs leading to respiratory distress.
Cerebral Hemorrhage
Severe hypertension increases the risk of stroke and intracranial bleeding.
Disseminated Intravascular Coagulation
Abnormal activation of coagulation pathways can lead to widespread bleeding and clot formation.
Hepatic Rupture
Rarely, severe liver involvement may result in hepatic hemorrhage or rupture, which can be fatal.
Fetal Complications
The fetus is highly vulnerable because placental insufficiency reduces oxygen and nutrient supply.
Intrauterine Growth Restriction
Poor placental perfusion restricts fetal growth and leads to low birth weight.
Prematurity
Many babies require early delivery because continuation of pregnancy becomes dangerous.
Premature infants may suffer from:
- Respiratory distress syndrome
- Feeding difficulties
- Hypothermia
- Infections
- Neurological complications
Fetal Hypoxia
Reduced placental blood flow decreases oxygen delivery to the fetus.
Stillbirth
Severe untreated disease may result in fetal death.
Neonatal Intensive Care Admission
Babies born to mothers with severe pre-eclampsia frequently require intensive neonatal care due to prematurity and low birth weight.
Management
Management of pre-eclampsia depends on:
- Gestational age
- Disease severity
- Maternal condition
- Fetal status
The only definitive cure is delivery of the placenta, but the timing of delivery must balance maternal safety against fetal maturity.
General Principles
The goals of management are:
- Control blood pressure
- Prevent seizures
- Monitor maternal organ function
- Assess fetal well-being
- Determine optimal timing of delivery
Women with mild disease may be managed conservatively under close supervision, whereas severe disease usually requires hospitalization.
Conservative Management
Mild pre-eclampsia near term may sometimes be managed expectantly with careful monitoring.
Management includes:
- Regular blood pressure monitoring
- Urine protein assessment
- Daily fetal movement counting
- Periodic laboratory investigations
- Fetal surveillance
Patients are advised to recognize warning symptoms such as severe headache, visual changes, abdominal pain, or reduced fetal movements.
Bed rest was traditionally recommended, but prolonged strict bed rest is no longer routinely advised because it may increase thromboembolic risk.
Nutritional counseling and adequate hydration are important supportive measures.
Antihypertensive Therapy
Control of blood pressure is one of the major components of managing Pre-eclampsia. Severe hypertension increases the risk of cerebral hemorrhage, stroke, heart failure, placental abruption, and maternal death. Antihypertensive medications are therefore administered to reduce these risks while maintaining adequate placental blood flow.
Treatment is usually initiated when:
- Systolic blood pressure is ≥160 mmHg
- Diastolic blood pressure is ≥110 mmHg
The aim is not to normalize blood pressure completely but to reduce it gradually to a safer range. Excessive reduction may compromise uteroplacental circulation and decrease fetal oxygen supply.
Commonly Used Antihypertensive Drugs
Labetalol
Labetalol is commonly used as a first-line drug because it effectively lowers blood pressure with relatively minimal effects on uteroplacental blood flow. It can be administered orally or intravenously.
Side effects may include:
- Fatigue
- Dizziness
- Bradycardia
- Hypotension
Hydralazine
Hydralazine is often used intravenously during hypertensive emergencies in pregnancy. It acts by relaxing vascular smooth muscle.
Adverse effects may include:
- Tachycardia
- Headache
- Flushing
- Nausea
Nifedipine
Nifedipine is another widely used antihypertensive drug in pregnancy. Oral nifedipine is effective in controlling acute severe hypertension.
Possible side effects include:
- Headache
- Palpitations
- Facial flushing
- Peripheral edema
Methyldopa
Methyldopa has historically been used in pregnancy due to its long safety record. It is mainly used for chronic blood pressure control rather than hypertensive emergencies.
Drugs Avoided in Pregnancy
Certain antihypertensive medications are contraindicated because they may harm the fetus.
These include:
- ACE inhibitors
- Angiotensin receptor blockers
- Direct renin inhibitors
These drugs may cause fetal renal damage, oligohydramnios, and congenital abnormalities.
Seizure Prophylaxis and Management
Prevention of seizures is a critical aspect of management in severe pre-eclampsia.
Magnesium Sulfate Therapy
Magnesium sulfate is the drug of choice for preventing and treating eclamptic seizures. It acts primarily by stabilizing cerebral blood vessels and reducing neuromuscular excitability.
It is administered:
- Intravenously
- Intramuscularly
- As loading and maintenance doses
Magnesium sulfate significantly reduces the risk of progression from pre-eclampsia to eclampsia.
Monitoring During Magnesium Therapy
Because magnesium toxicity can occur, careful monitoring is essential.
Healthcare providers monitor:
- Deep tendon reflexes
- Respiratory rate
- Urine output
- Level of consciousness
Loss of reflexes may indicate early toxicity.
Severe toxicity can cause:
- Respiratory depression
- Cardiac arrest
- Muscle paralysis
Antidote
Calcium gluconate is used as the antidote in cases of magnesium sulfate toxicity.
Fluid Management
Fluid balance in pre-eclampsia requires careful attention because both fluid overload and dehydration can be dangerous.
Excessive intravenous fluids may lead to pulmonary edema due to increased capillary permeability. On the other hand, inadequate fluid replacement may worsen renal perfusion and fetal circulation.
Urine output is closely monitored because oliguria may indicate worsening renal involvement.
Fluid management principles include:
- Strict intake-output charting
- Avoidance of fluid overload
- Careful intravenous fluid administration
- Monitoring for pulmonary edema
Delivery Management
Delivery is the definitive treatment for pre-eclampsia because removal of the placenta eliminates the primary disease process.
The timing of delivery depends on:
- Gestational age
- Severity of maternal disease
- Fetal condition
- Response to treatment
Indications for Immediate Delivery
Urgent delivery may be required if there is:
- Uncontrolled severe hypertension
- Eclampsia
- HELLP syndrome
- Placental abruption
- Pulmonary edema
- Fetal distress
- Severe fetal growth restriction
- Disseminated intravascular coagulation
Vaginal Delivery
If maternal and fetal conditions are stable, vaginal delivery may be attempted. Labor induction can be performed using prostaglandins or oxytocin.
Cesarean Section
Cesarean delivery may be required in cases of:
- Severe fetal distress
- Failed induction
- Placental abruption
- Unstable maternal condition
The mode of delivery is individualized based on obstetric and medical factors.
Intrapartum Care
Women with severe pre-eclampsia require intensive monitoring during labor.
Important aspects include:
- Frequent blood pressure monitoring
- Continuous fetal heart monitoring
- Monitoring urine output
- Observation for seizures
- Assessment of reflexes
- Monitoring oxygen saturation
Pain relief during labor is important because severe pain may increase blood pressure further.
Epidural anesthesia may be used if coagulation status is normal.
Postpartum Management
Pre-eclampsia does not immediately resolve after delivery. Maternal complications may still occur during the postpartum period, especially within the first 48 hours.
Blood pressure often remains elevated for several days and may temporarily worsen after delivery.
Women require continued monitoring for:
- Hypertension
- Seizures
- Pulmonary edema
- Renal dysfunction
- Hemorrhage
Magnesium sulfate is usually continued for 24 hours after delivery to prevent postpartum seizures.
Antihypertensive therapy may still be necessary postpartum. Blood pressure generally returns to normal within weeks, although some women remain hypertensive long term.
Nursing Management
Nursing care plays a vital role in improving maternal and fetal outcomes.
Assessment and Monitoring
Nurses regularly assess:
- Blood pressure
- Pulse
- Respiratory rate
- Reflexes
- Oxygen saturation
- Urine output
- Fetal heart rate
Observation for warning signs such as headache, blurred vision, chest pain, or reduced urine output is essential.
Seizure Precautions
Patients with severe disease require seizure precautions including:
- Quiet environment
- Reduced stimulation
- Padded side rails
- Emergency equipment nearby
Medication Administration
Nurses administer antihypertensive drugs and magnesium sulfate while monitoring for adverse effects and toxicity.
Emotional Support
Pregnancy complications often cause significant anxiety and emotional distress. Psychological support and reassurance are important components of care.
Education
Patients and families are educated about:
- Warning signs
- Medication adherence
- Importance of follow-up
- Blood pressure monitoring
- Future pregnancy risks
Prevention
Although pre-eclampsia cannot always be prevented, certain strategies reduce the risk in high-risk women.
Antenatal Care
Regular prenatal visits allow early detection of hypertension and proteinuria.
Low-Dose Aspirin
Aspirin in low doses may reduce the risk of pre-eclampsia in high-risk women when started early in pregnancy.
Calcium Supplementation
Adequate calcium intake may reduce risk in populations with low dietary calcium.
Healthy Lifestyle Measures
Preventive lifestyle strategies include:
- Weight control
- Healthy diet
- Regular physical activity
- Management of chronic diseases
- Avoidance of smoking
Women with previous pre-eclampsia require careful monitoring in future pregnancies because recurrence risk is increased.
Long-Term Maternal Effects
Women who develop pre-eclampsia have increased long-term risk of cardiovascular and metabolic disease later in life.
These include:
- Chronic hypertension
- Ischemic heart disease
- Stroke
- Kidney disease
- Diabetes mellitus
The disorder is therefore considered an early marker of future cardiovascular risk.
Long-term follow-up and lifestyle modification are recommended after affected pregnancies.
Prognosis
The prognosis depends on:
- Severity of disease
- Gestational age at onset
- Availability of medical care
- Presence of complications
Mild disease detected near term usually has favorable outcomes with proper management. Early-onset severe disease carries higher risks for both mother and fetus.
Advances in obstetric care, antihypertensive therapy, intensive monitoring, and neonatal care have greatly improved survival rates, but pre-eclampsia remains one of the leading causes of maternal and perinatal morbidity worldwide.
Differential Diagnosis
Several medical conditions may resemble Pre-eclampsia because they also present with hypertension, proteinuria, edema, or organ dysfunction during pregnancy. Accurate differentiation is important because treatment and prognosis may differ significantly.
Chronic Hypertension
Women with chronic hypertension already have elevated blood pressure before pregnancy or before 20 weeks of gestation. In contrast, pre-eclampsia develops after 20 weeks.
However, distinguishing between chronic hypertension and superimposed pre-eclampsia can sometimes be difficult, especially when baseline laboratory investigations are unavailable.
Features suggesting superimposed pre-eclampsia include:
- Sudden worsening of blood pressure
- New-onset proteinuria
- Elevated liver enzymes
- Thrombocytopenia
- Rapid edema formation
Gestational Hypertension
Gestational hypertension refers to elevated blood pressure after 20 weeks of pregnancy without proteinuria or systemic involvement.
Some women with gestational hypertension eventually progress to pre-eclampsia, particularly if hypertension becomes severe.
Chronic Kidney Disease
Renal diseases may cause hypertension and proteinuria similar to pre-eclampsia.
Features favoring chronic kidney disease include:
- Proteinuria before pregnancy
- Abnormal renal function before 20 weeks
- History of renal disease
- Persistent proteinuria postpartum
Thrombotic Microangiopathies
Conditions such as thrombotic thrombocytopenic purpura and hemolytic uremic syndrome may mimic severe pre-eclampsia or HELLP syndrome.
These disorders also present with:
- Hemolysis
- Thrombocytopenia
- Renal impairment
- Neurological symptoms
Acute Fatty Liver of Pregnancy
Acute fatty liver of pregnancy may resemble severe pre-eclampsia because both conditions can involve liver dysfunction, abdominal pain, nausea, and coagulation abnormalities.
HELLP Syndrome
HELLP syndrome is considered a severe variant of pre-eclampsia and represents one of the most dangerous obstetric emergencies.
The acronym HELLP stands for:
- Hemolysis
- Elevated Liver enzymes
- Low Platelet count
The syndrome may occur:
- Before delivery
- During labor
- After delivery
Some women develop HELLP syndrome without severe hypertension, making diagnosis challenging.
Pathophysiology of HELLP Syndrome
Widespread endothelial injury and activation of coagulation pathways lead to:
- Microvascular thrombosis
- Red blood cell destruction
- Hepatic ischemia
- Platelet consumption
The liver becomes swollen and inflamed, which may cause severe right upper quadrant pain.
Clinical Features
Common symptoms include:
- Severe epigastric pain
- Nausea and vomiting
- Malaise
- Headache
- Visual disturbances
- Hypertension
- Proteinuria
Patients may appear seriously ill and deteriorate rapidly.
Complications
HELLP syndrome may cause:
- Liver hematoma
- Hepatic rupture
- Disseminated intravascular coagulation
- Acute kidney injury
- Placental abruption
- Pulmonary edema
- Maternal death
Management
Immediate stabilization is required with:
- Blood pressure control
- Magnesium sulfate
- Blood product replacement if needed
- Careful monitoring
- Prompt delivery
Eclampsia
Eclampsia is defined as the occurrence of generalized tonic-clonic seizures in a woman with pre-eclampsia that cannot be attributed to other neurological causes.
It is one of the most severe complications of hypertensive disorders in pregnancy.
Pathogenesis
The exact mechanism is not fully understood, but cerebral vasospasm, edema, ischemia, and endothelial dysfunction are believed to contribute.
Seizures may occur:
- Antepartum
- Intrapartum
- Postpartum
Most cases occur after 28 weeks of gestation.
Warning Symptoms
Many women experience warning signs before seizures develop, including:
- Severe headache
- Blurred vision
- Photophobia
- Hyperreflexia
- Epigastric pain
- Mental confusion
However, seizures may also occur suddenly without warning.
Characteristics of Seizures
The seizures are usually generalized tonic-clonic in nature and may last approximately one minute.
Following the seizure, the patient may develop:
- Confusion
- Agitation
- Coma
- Respiratory distress
Repeated seizures significantly increase the risk of hypoxia and cerebral injury.
Emergency Management
Management priorities include:
- Airway protection
- Oxygen administration
- Prevention of maternal injury
- Seizure control
- Blood pressure stabilization
- Fetal monitoring
Magnesium Sulfate in Eclampsia
Magnesium sulfate remains the treatment of choice for controlling and preventing recurrent seizures.
It is superior to other anticonvulsants such as diazepam or phenytoin in reducing maternal morbidity and mortality.
Maternal Complications of Eclampsia
Potential complications include:
- Aspiration pneumonia
- Cerebral hemorrhage
- Cardiac arrest
- Pulmonary edema
- Kidney injury
- Disseminated intravascular coagulation
Fetal Complications
The fetus may suffer from:
- Hypoxia
- Bradycardia
- Prematurity
- Placental abruption
- Stillbirth
Placental Changes in Pre-eclampsia
The placenta in pre-eclampsia often shows characteristic pathological abnormalities resulting from poor blood flow and ischemia.
Gross Placental Findings
The placenta may appear:
- Small
- Infarcted
- Pale
- Calcified
Placental infarctions occur due to vascular insufficiency and thrombosis.
Microscopic Findings
Microscopic examination may reveal:
- Fibrinoid necrosis
- Atherosis of spiral arteries
- Thrombosis
- Villous hypoplasia
- Ischemic changes
These abnormalities impair maternal-fetal exchange of oxygen and nutrients.
Effects on Fetal Growth
Because placental circulation is compromised, fetal growth restriction commonly develops.
Reduced oxygen delivery may also cause:
- Chronic fetal hypoxia
- Reduced amniotic fluid
- Abnormal fetal heart patterns
Cardiovascular Changes
Pre-eclampsia profoundly affects the maternal cardiovascular system.
Vasospasm
Generalized vasoconstriction increases systemic vascular resistance and raises blood pressure.
Endothelial Dysfunction
Damaged vascular endothelium loses its ability to regulate vascular tone properly.
This leads to:
- Increased permeability
- Platelet aggregation
- Coagulation activation
Reduced Plasma Volume
Despite edema, intravascular volume may actually be reduced because fluid leaks into tissues.
Cardiac Effects
Severe disease increases cardiac workload and may contribute to:
- Heart failure
- Pulmonary edema
- Myocardial ischemia
Renal Changes
The kidneys are among the organs most commonly affected in pre-eclampsia.
Glomerular Endotheliosis
The hallmark renal lesion is glomerular endotheliosis, characterized by swelling of glomerular endothelial cells.
This results in:
- Reduced filtration
- Proteinuria
- Fluid retention
Reduced Renal Perfusion
Vasospasm decreases renal blood flow and glomerular filtration rate.
Oliguria
Severe renal involvement may reduce urine output significantly.
Acute Kidney Injury
Persistent severe disease may eventually lead to acute renal failure requiring intensive care support.
Hepatic Changes
Liver involvement occurs due to endothelial injury and hepatic ischemia.
Elevated Liver Enzymes
Hepatocellular injury increases AST and ALT levels.
Hepatic Edema
Swelling of the liver stretches Glisson’s capsule and causes severe right upper quadrant pain.
Subcapsular Hematoma
Rarely, bleeding beneath the liver capsule may develop.
Hepatic Rupture
Severe hepatic injury may lead to rupture, massive hemorrhage, shock, and death.
Neurological Changes
The nervous system is particularly vulnerable in severe pre-eclampsia.
Cerebral Edema
Endothelial dysfunction increases vascular permeability and fluid leakage into brain tissue.
Vasospasm
Cerebral vasospasm reduces blood flow and may cause ischemia.
Symptoms
Neurological manifestations include:
- Severe headache
- Hyperreflexia
- Visual disturbances
- Confusion
- Seizures
Posterior Reversible Encephalopathy Syndrome
Posterior reversible encephalopathy syndrome may occur in severe cases and presents with:
- Headache
- Altered consciousness
- Seizures
- Visual loss
MRI often shows edema in posterior brain regions.
Respiratory Changes
Respiratory complications in Pre-eclampsia mainly result from endothelial dysfunction, increased vascular permeability, fluid overload, and cardiac impairment. Pulmonary complications are especially dangerous because they may rapidly progress to respiratory failure.
Pulmonary Edema
Pulmonary edema is one of the most serious respiratory complications of severe pre-eclampsia. Increased capillary permeability allows fluid to leak into the lung tissues and alveoli. Reduced plasma oncotic pressure and left ventricular dysfunction may worsen the condition.
Common symptoms include:
- Shortness of breath
- Tachypnea
- Orthopnea
- Chest tightness
- Cyanosis
- Persistent cough
On examination, crackles may be heard over the lungs, and oxygen saturation may be reduced.
Pulmonary edema requires immediate treatment with:
- Oxygen therapy
- Fluid restriction
- Diuretics in selected cases
- Blood pressure control
- Intensive monitoring
Acute Respiratory Distress Syndrome
Severe endothelial injury and systemic inflammation may trigger acute respiratory distress syndrome. This condition is characterized by severe hypoxemia and diffuse lung injury.
Patients often require:
- Intensive care
- Mechanical ventilation
- Hemodynamic support
Aspiration Pneumonia
Women who develop eclamptic seizures are at risk of aspiration of gastric contents into the lungs, especially if airway protection is inadequate during convulsions.
Hematological Changes
Pre-eclampsia significantly affects the coagulation system and blood components.
Thrombocytopenia
Low platelet count occurs due to increased platelet activation and consumption. It is one of the most common hematological abnormalities in severe disease.
A rapidly falling platelet count may indicate:
- Severe pre-eclampsia
- HELLP syndrome
- Disseminated intravascular coagulation
Hemoconcentration
Plasma leakage into tissues reduces intravascular fluid volume and increases hematocrit concentration.
Hemolysis
Microangiopathic hemolysis occurs when red blood cells are damaged while passing through narrowed blood vessels containing fibrin deposits.
Laboratory evidence includes:
- Elevated LDH
- Reduced haptoglobin
- Fragmented red blood cells
Disseminated Intravascular Coagulation
Disseminated intravascular coagulation is a life-threatening complication involving widespread activation of the coagulation system.
This condition causes:
- Consumption of clotting factors
- Excessive bleeding
- Formation of microthrombi
- Organ ischemia
Patients may develop bleeding from:
- Intravenous sites
- Surgical wounds
- Gums
- Gastrointestinal tract
Endocrine and Metabolic Changes
Pre-eclampsia also influences metabolic and endocrine functions.
Insulin Resistance
Women with pre-eclampsia often exhibit increased insulin resistance similar to metabolic syndrome.
Lipid Abnormalities
Abnormal lipid metabolism contributes to endothelial dysfunction and oxidative stress.
Common findings include:
- Elevated triglycerides
- Increased LDL cholesterol
- Reduced HDL cholesterol
Oxidative Stress
Placental ischemia generates excessive free radicals that damage vascular endothelium and worsen systemic inflammation.
Immunological Factors
Immune maladaptation between maternal and fetal tissues contributes significantly to the development of pre-eclampsia.
Maternal Immune Response
Normally, maternal immunity adapts to tolerate fetal antigens. In pre-eclampsia, this adaptation may be defective.
Abnormal immune activation promotes:
- Inflammation
- Endothelial injury
- Vasoconstriction
Cytokine Imbalance
Increased inflammatory cytokines and reduced protective factors contribute to vascular dysfunction.
Autoimmune Associations
Women with autoimmune disorders such as:
- Systemic lupus erythematosus
- Antiphospholipid syndrome
have significantly increased risk of developing severe pre-eclampsia.
Genetic Factors
Genetic predisposition plays an important role in susceptibility to pre-eclampsia.
Family History
Women with affected mothers or sisters have increased risk, suggesting inherited susceptibility.
Paternal Contribution
Paternal genes may influence placental development because the placenta contains fetal genetic material from both parents.
Candidate Genes
Researchers have identified associations with genes related to:
- Angiogenesis
- Endothelial function
- Immune regulation
- Oxidative stress
However, pre-eclampsia is considered a multifactorial disorder involving multiple interacting genes and environmental factors.
Placental Ischemia and Angiogenic Imbalance
Abnormal placentation is central to disease development.
Reduced Placental Perfusion
Poor remodeling of spiral arteries limits maternal blood supply to the placenta.
This causes:
- Chronic placental hypoxia
- Oxidative stress
- Placental infarction
Antiangiogenic Factors
The ischemic placenta releases antiangiogenic proteins such as:
- Soluble fms-like tyrosine kinase-1 (sFlt-1)
- Soluble endoglin
These substances interfere with vascular endothelial growth factor activity and damage maternal endothelium.
Endothelial Dysfunction
The resulting endothelial injury causes:
- Hypertension
- Proteinuria
- Organ ischemia
- Coagulation abnormalities
Early-Onset and Late-Onset Pre-eclampsia
Pre-eclampsia is increasingly recognized as having different subtypes.
Early-Onset Disease
Early-onset pre-eclampsia develops before 34 weeks of gestation and is strongly associated with severe placental dysfunction.
Characteristics include:
- Severe hypertension
- Marked fetal growth restriction
- Abnormal Doppler studies
- Higher maternal complications
- Increased neonatal mortality
Late-Onset Disease
Late-onset disease occurs after 34 weeks and is generally associated with milder placental abnormalities.
Maternal metabolic factors such as obesity and chronic hypertension may contribute more prominently in this subtype.
Maternal Mortality
Pre-eclampsia remains one of the leading causes of maternal death worldwide.
Major causes of maternal mortality include:
- Cerebral hemorrhage
- Eclampsia
- Pulmonary edema
- Disseminated intravascular coagulation
- Liver rupture
- Renal failure
Early diagnosis and access to emergency obstetric care significantly reduce mortality rates.
Perinatal Mortality
The fetus is also at significant risk because placental dysfunction compromises oxygen and nutrient delivery.
Major causes of fetal and neonatal death include:
- Prematurity
- Severe fetal growth restriction
- Placental abruption
- Birth asphyxia
- Stillbirth
Advances in neonatal intensive care have improved survival of premature infants born to mothers with severe disease.
Public Health Importance
Pre-eclampsia is a major global health issue affecting millions of pregnancies annually.
The condition places significant burden on healthcare systems because it often requires:
- Hospitalization
- Intensive monitoring
- Emergency delivery
- Neonatal intensive care
In low-resource settings, delayed diagnosis and inadequate access to healthcare contribute to high mortality rates.
Improving antenatal care services is essential for reducing complications associated with hypertensive disorders in pregnancy.
Screening and Prediction
Researchers continue to explore methods for early prediction of pre-eclampsia.
Clinical Risk Assessment
Women are screened for known risk factors during early pregnancy.
Blood Pressure Monitoring
Regular blood pressure measurement remains one of the simplest and most effective screening methods.
Biomarkers
Several biochemical markers are under investigation including:
- Placental growth factor
- sFlt-1
- Pregnancy-associated plasma protein A
These markers may help identify high-risk women before symptoms appear.
Doppler Ultrasound
Abnormal uterine artery Doppler findings during the second trimester may indicate impaired placental circulation and increased risk of pre-eclampsia.
Lifestyle and Nutritional Factors
Nutrition and maternal lifestyle may influence disease risk.
Obesity
Obesity significantly increases the likelihood of:
- Hypertension
- Insulin resistance
- Endothelial dysfunction
Dietary Factors
Poor nutritional intake, especially low calcium intake, may contribute to increased risk in some populations.
Physical Activity
Moderate physical activity during pregnancy may improve vascular health and reduce metabolic risk factors.
Smoking
Although smoking paradoxically appears associated with reduced incidence of pre-eclampsia, it is strongly discouraged because it causes severe maternal and fetal harm including:
- Placental insufficiency
- Prematurity
- Low birth weight
- Fetal death
.jpeg)
